AbbVie registers Phase 1 PK study of trosunilimab given IV and SC in healthy adultsNov 13Weekly roundup, 8 itemsABBV-295ABBV-722
AbbVie's CANASA label update and ABBV-253 trial recruitment lead busy week of registry changesOct 16Weekly roundup, 9 itemsABBV-1042ABBV-253Updated
AbbVie posts TEMPLE Phase 3 results for atogepant vs topiramate; opens three early-stage trialsJul 2Weekly roundup, 5 itemsABBV-313AbbVie